Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Nidhya Navanandan

Concepts (107)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
14
2024
2219
3.820
Why?
Anti-Asthmatic Agents
5
2024
373
1.850
Why?
Pneumonia
7
2023
599
1.370
Why?
Emergency Service, Hospital
12
2024
1973
1.360
Why?
Respiratory Tract Infections
4
2024
372
1.050
Why?
Respiratory Sounds
2
2024
121
1.040
Why?
Community-Acquired Infections
5
2023
152
0.890
Why?
Recurrence
2
2024
1003
0.880
Why?
Child
26
2024
20806
0.810
Why?
Virus Diseases
2
2023
209
0.780
Why?
Severity of Illness Index
4
2024
2739
0.740
Why?
Airway Resistance
1
2020
38
0.690
Why?
Oscillometry
1
2020
37
0.680
Why?
Adrenal Cortex Hormones
4
2024
519
0.650
Why?
Medicaid
1
2024
437
0.650
Why?
Staphylococcus aureus
1
2023
431
0.640
Why?
Child, Preschool
13
2024
10451
0.600
Why?
Glucocorticoids
2
2020
575
0.580
Why?
Patient Discharge Summaries
1
2017
10
0.550
Why?
Biomedical Research
1
2023
647
0.540
Why?
Physicians, Primary Care
1
2020
227
0.540
Why?
Positive-Pressure Respiration
1
2017
75
0.530
Why?
Pulmonary Embolism
1
2019
208
0.530
Why?
Dexamethasone
3
2024
340
0.480
Why?
Health Literacy
1
2017
162
0.460
Why?
Emergency Medical Services
2
2021
550
0.460
Why?
Prednisone
3
2020
236
0.450
Why?
Physicians
1
2022
861
0.440
Why?
Prospective Studies
10
2024
7079
0.400
Why?
Acute Disease
4
2024
968
0.380
Why?
Humans
28
2024
129136
0.380
Why?
Bronchodilator Agents
3
2024
245
0.370
Why?
Patient Readmission
1
2017
668
0.370
Why?
Prednisolone
2
2020
82
0.340
Why?
Caregivers
1
2017
812
0.330
Why?
Male
14
2024
63203
0.280
Why?
Patient Discharge
3
2024
857
0.260
Why?
Disease Progression
2
2024
2613
0.240
Why?
Hospitalization
4
2022
2077
0.240
Why?
Infant
7
2024
8993
0.240
Why?
Risk Factors
4
2024
9769
0.230
Why?
Rhinovirus
1
2024
56
0.230
Why?
Picornaviridae Infections
1
2024
45
0.220
Why?
Quality of Life
4
2024
2694
0.220
Why?
Enterotoxins
1
2023
89
0.210
Why?
Female
12
2024
68519
0.210
Why?
Bronchiolitis
1
2024
89
0.200
Why?
Respiratory Syncytial Virus, Human
1
2023
68
0.200
Why?
Viruses
1
2023
99
0.200
Why?
Respiratory Syncytial Virus Infections
1
2023
120
0.190
Why?
Magnesium
1
2022
151
0.190
Why?
Educational Status
1
2024
473
0.190
Why?
Administration, Intravenous
1
2022
137
0.190
Why?
Delphi Technique
1
2023
226
0.190
Why?
Dyspnea
1
2023
239
0.180
Why?
Schools
1
2024
439
0.170
Why?
Allergens
1
2023
383
0.170
Why?
Surveys and Questionnaires
2
2023
5377
0.170
Why?
Consensus
1
2023
638
0.160
Why?
Thrombectomy
1
2019
59
0.150
Why?
Administration, Oral
1
2020
759
0.150
Why?
Adolescent
5
2024
20302
0.150
Why?
Vena Cava Filters
1
2019
59
0.150
Why?
Self Report
1
2022
806
0.150
Why?
Infant, Newborn
3
2024
5739
0.140
Why?
Ipratropium
1
2017
6
0.140
Why?
Influenza, Human
1
2023
601
0.140
Why?
Nebulizers and Vaporizers
1
2017
82
0.130
Why?
Albuterol
1
2017
104
0.130
Why?
Feasibility Studies
1
2020
862
0.130
Why?
Retrospective Studies
3
2024
14571
0.130
Why?
Single-Blind Method
1
2017
269
0.130
Why?
Sepsis
1
2022
557
0.130
Why?
Tertiary Care Centers
1
2017
147
0.130
Why?
Phenotype
1
2023
3058
0.120
Why?
Prognosis
1
2023
3788
0.120
Why?
Health Surveys
1
2017
492
0.120
Why?
Anticoagulants
1
2019
614
0.110
Why?
Combined Modality Therapy
1
2017
1209
0.110
Why?
Treatment Outcome
2
2024
10227
0.100
Why?
Ambulatory Care
1
2017
506
0.100
Why?
Patient Satisfaction
1
2017
647
0.100
Why?
Biomarkers
1
2023
3897
0.100
Why?
Primary Health Care
1
2020
1641
0.080
Why?
United States
2
2024
13941
0.080
Why?
Pediatrics
1
2017
1062
0.080
Why?
Health Knowledge, Attitudes, Practice
1
2017
1275
0.070
Why?
Adult
2
2020
35513
0.060
Why?
Uncertainty
1
2024
117
0.050
Why?
Patient Acuity
1
2022
45
0.050
Why?
Treatment Failure
1
2024
343
0.050
Why?
Anti-Bacterial Agents
2
2022
1671
0.050
Why?
Fever
1
2022
301
0.050
Why?
Aftercare
1
2022
206
0.040
Why?
ROC Curve
1
2022
502
0.040
Why?
Young Adult
1
2017
12389
0.040
Why?
Epinephrine
1
2021
138
0.040
Why?
Fatigue
1
2022
320
0.040
Why?
Pneumonia, Viral
1
2024
343
0.040
Why?
Odds Ratio
1
2022
1025
0.040
Why?
Hospitals, Pediatric
1
2022
517
0.040
Why?
Middle Aged
1
2020
31080
0.040
Why?
Tomography, X-Ray Computed
1
2024
2541
0.030
Why?
Follow-Up Studies
1
2022
4915
0.030
Why?
Cohort Studies
1
2022
5407
0.020
Why?
Cross-Sectional Studies
1
2022
5070
0.020
Why?
Lung
1
2024
3753
0.020
Why?
Navanandan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)